EDGAR Filing Documents for 0001415889-15-001677

Form 8-K - Current report:

SEC Accession No. 0001415889-15-001677

Filing Date

2015-05-13

Accepted

2015-05-13 17:18:58

Documents

Period of Report

2015-05-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	vsta8k_may72015.htm	8-K	48122
2	CERTIFICATE OF DESIGNATION OF THE RELATIVE RIGHTS AND PREFERENCES OF THE SERIES	ex3-1.htm	EX-3.1	130657
3	AGREEMENT, BY AND BETWEEN VISTAGEN THERAPEUTICS, INC. AND PLATINUM LONG TERM GRO	ex10-1.htm	EX-10.1	71733
4	ACKNOWLEDGEMENT AND AGREEMENT, BY AND BETWEEN VISTAGEN THERAPEUTICS, INC. AND PL	ex10-2.htm	EX-10.2	13150
5	FORM OF SECURITIES PURCHASE AGREEMENT BY AND BETWEEN VISTAGEN THERAPEUTICS, INC.	ex10-3.htm	EX-10.3	272616
	Complete submission text file	0001415889-15-001677.txt		537644

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990

VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)